Cargando…
The Metabolic Efficacy of a Cannabidiolic Acid (CBDA) Derivative in Treating Diet- and Genetic-Induced Obesity
Obesity is a global medical problem; its common form is known as diet-induced obesity (DIO); however, there are several rare genetic disorders, such as Prader–Willi syndrome (PWS), that are also associated with obesity (genetic-induced obesity, GIO). The currently available therapeutics for treating...
Autores principales: | Ben-Cnaan, Elad, Permyakova, Anna, Azar, Shahar, Hirsch, Shira, Baraghithy, Saja, Hinden, Liad, Tam, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144717/ https://www.ncbi.nlm.nih.gov/pubmed/35628417 http://dx.doi.org/10.3390/ijms23105610 |
Ejemplares similares
-
Hepatic targeting of the centrally active cannabinoid 1 receptor (CB(1)R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes
por: Hirsch, Shira, et al.
Publicado: (2023) -
Renal Proximal Tubule Cell Cannabinoid-1 Receptor Regulates Bone Remodeling and Mass via a Kidney-to-Bone Axis
por: Baraghithy, Saja, et al.
Publicado: (2021) -
A Novel Indoline Derivative Ameliorates Diabesity-Induced Chronic Kidney Disease by Reducing Metabolic Abnormalities
por: Permyakova, Anna, et al.
Publicado: (2020) -
Short term feeding of industrial hemp with a high cannabidiolic acid (CBDA) content increases lying behavior and reduces biomarkers of stress and inflammation in Holstein steers
por: Kleinhenz, Michael D., et al.
Publicado: (2022) -
CB(1)R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance
por: Drori, Adi, et al.
Publicado: (2020)